Specific receptors for adrenomedullin in cultured rat vascular smooth muscle cells

FEBS Lett. 1994 Mar 7;340(3):226-30. doi: 10.1016/0014-5793(94)80143-6.

Abstract

The effects of synthetic rat adrenomedullin (rAM), a novel vasorelaxant peptide originally isolated from human pheochromocytoma, on receptor binding and cAMP generation were studied in cultured rat vascular smooth muscle cells (VSMC). A binding study using [125I]rAM revealed the presence of a single class of high-affinity (Kd 1.3 x 10(-8) M) binding sites for rAM in VSMC. The apparent Ki of rat calcitonin gene-related peptide (rCGRP) was 3 x 10(-7) M. Affinity labeling of VSMC membranes with [125I]rAM revealed two distinct labeled bands with apparent molecular weights of 120 and 70 kDa, both of which were abolished by excess unlabeled rAM or rCGRP, rAM stimulated cAMP formation with an approximate EC50 of 10(-8) M, the effect of which was additive with isoproterenol, but not with rCGRP. The rAM-induced cAMP response was unaffected by propranolol, indomethacin, or quinacrine, but inhibited by a CGRP receptor antagonist, human CGRP[8-37]. These data suggest that VSMC possesses specific AM receptors functionally coupled to adenylate cyclase with which CGRP interacts.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adrenomedullin
  • Affinity Labels
  • Animals
  • Binding, Competitive
  • Calcitonin Gene-Related Peptide / metabolism
  • Cells, Cultured
  • Cyclic AMP / metabolism
  • Humans
  • Muscle, Smooth, Vascular / cytology
  • Muscle, Smooth, Vascular / metabolism*
  • Peptides / metabolism*
  • Rats
  • Receptors, Cell Surface / analysis*
  • Recombinant Proteins / metabolism

Substances

  • Affinity Labels
  • Peptides
  • Receptors, Cell Surface
  • Recombinant Proteins
  • Adrenomedullin
  • Cyclic AMP
  • Calcitonin Gene-Related Peptide